{"result": "\n{\n    \"title\": \"ProCESS Trial and Early Goal-Directed Therapy\",\n    \"summary\": \"The community centers around the ProCESS trial, a significant clinical study evaluating Early Goal-Directed Therapy (EGDT) for septic shock. Key entities include Edwards Lifesciences, which provided essential equipment, and Rivers et al., whose earlier research laid the groundwork for EGDT. The trial was funded by the National Institute of General Medical Sciences and managed by the University of Pittsburgh, highlighting a collaborative effort in advancing sepsis treatment.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the ProCESS trial's significant contributions to medical protocols for treating septic shock, influencing clinical practices globally.\",\n    \"findings\": [\n        {\n            \"summary\": \"ProCESS Trial's pivotal role in sepsis treatment\",\n            \"explanation\": \"The ProCESS trial, conducted across 31 emergency departments in the United States, was a landmark study evaluating the effectiveness of Early Goal-Directed Therapy (EGDT) in managing septic shock. This trial provided critical insights into protocol-based resuscitation, reporting lower-than-anticipated mortality rates, which have influenced clinical practices worldwide [Data: Entities (247); Relationships (142, 235, 684, 687, 685)].\"\n        },\n        {\n            \"summary\": \"Edwards Lifesciences' contribution to the trial\",\n            \"explanation\": \"Edwards Lifesciences played a crucial role in the ProCESS trial by providing ScvO2 monitors and technical support, which were integral to the EGDT protocol. Their involvement ensured the effective implementation of the trial's resuscitation strategies, highlighting the importance of industry collaboration in clinical research [Data: Entities (244); Relationships (678, 679, 680, 681)].\"\n        },\n        {\n            \"summary\": \"Rivers et al.'s foundational research\",\n            \"explanation\": \"The research conducted by Rivers et al. in 2001 on Early Goal-Directed Therapy (EGDT) served as a foundation for the ProCESS trial. Their study demonstrated the efficacy of early resuscitation in reducing mortality, and their protocol was mimicked in the ProCESS trial, underscoring their lasting impact on sepsis treatment [Data: Entities (248); Relationships (690, 688, 689)].\"\n        },\n        {\n            \"summary\": \"Funding and management by key institutions\",\n            \"explanation\": \"The ProCESS trial was funded by the National Institute of General Medical Sciences, reflecting the importance of governmental support in advancing medical research. The University of Pittsburgh managed the trial's data, ensuring rigorous oversight and integrity in the study's execution [Data: Entities (242, 243); Relationships (675, 677, 683)].\"\n        },\n        {\n            \"summary\": \"Comparison of resuscitation strategies\",\n            \"explanation\": \"The ProCESS trial compared different resuscitation strategies, including EGDT, protocol-based standard therapy, and usual care. This comparative analysis provided valuable insights into the effectiveness of various treatment protocols, influencing clinical guidelines for managing septic shock [Data: Entities (253, 252); Relationships (699, 684, 697, 698)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n247,PROCESS TRIAL,\"The ProCESS trial, also known as the Protocolized Care for Early Septic Shock trial, is a multicenter, randomized clinical trial conducted in the United States. It was designed to evaluate the effectiveness of protocol-based care, specifically Early Goal-Directed Therapy (EGDT), versus usual care in patients with severe conditions, particularly those experiencing septic shock. The trial aimed to assess the outcomes of protocol-based resuscitation in these patients and reported lower-than-anticipated mortality rates.\",11\n244,EDWARDS LIFESCIENCES,\"Edwards Lifesciences is a company based in Irvine, California, that specializes in providing medical devices, particularly for monitoring central venous oxygen saturation (ScvO2). In the context of a study, Edwards Lifesciences played a crucial role by loaning ScvO2 monitors to participating sites. Additionally, the company provided essential training and technical support to ensure the effective use of their equipment during the trial.\",5\n248,RIVERS ET AL.,\"Rivers et al. refers to a group of researchers who conducted a landmark study in 2001 on early goal-directed therapy (EGDT) for patients with severe sepsis or septic shock. Their research demonstrated the efficacy of early, goal-directed resuscitation, reporting lower mortality rates in these patients. The study by Rivers et al. is frequently referenced for comparison in subsequent studies, and their protocol has been mimicked in protocol-based EGDT interventions. Additionally, Rivers et al. conducted a study on adherence to the EGDT protocol, further solidifying their contribution to the field of sepsis treatment.\",5\n242,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,\"The National Institute of General Medical Sciences, a part of the National Institutes of Health, supports research aimed at increasing the understanding of biological processes. This foundational work is crucial for advancing disease diagnosis, treatment, and prevention. Additionally, the institute is known for funding significant research initiatives, such as the ProCESS trial.\",2\n253,PROTOCOL-BASED STANDARD THERAPY,\"PROTOCOL-BASED STANDARD THERAPY is a treatment strategy used in a study as a comparison to Early Goal-Directed Therapy (EGDT) and usual care. This intervention involves less aggressive resuscitation instructions than EGDT, utilizing peripheral venous access for the administration of fluids and vasoactive agents.\",2\n249,EARLY GOAL-DIRECTED THERAPY (EGDT),,2\n245,CRISMA CENTER,\"The University of Pittsburgh Clinical Research, Investigation, and Systems Modeling of Acute Illness Center that managed data for the trial\",1\n268,SERUM LACTATE LEVEL,\"A clinical measurement used to assess the severity of shock in patients, referenced in the study for subgroup analysis\",1\n243,UNIVERSITY OF PITTSBURGH,The institution that managed the data for the ProCESS trial and had its institutional review board approve the study,1\n252,PROTOCOL-BASED EGDT,\"A study intervention involving protocol-guided resuscitation interventions, including central venous catheter placement and administration of fluids and vasopressors\",2\n510,IRVINE,Irvine is a city in California where Edwards Lifesciences is located,1\n255,PROCESS INVESTIGATORS,Researchers who designed the protocol-based standard-therapy approach based on literature review and surveys,2\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n142,SEPTIC SHOCK,PROCESS TRIAL,The ProCESS trial evaluated the effectiveness of EGDT in patients with septic shock,81\n687,PROCESS TRIAL,EGDT,\"The ProCESS trial evaluated protocol-based resuscitation, including Early Goal-Directed Therapy (EGDT), in patients with septic shock. This trial specifically assessed the effectiveness of EGDT in managing septic shock within the United States.\",62\n679,EDWARDS LIFESCIENCES,EGDT,Edwards Lifesciences provided ScvO2 monitors used in the EGDT treatment protocol,56\n690,RIVERS ET AL.,EGDT,\"Rivers et al. conducted a study focusing on the adherence to the Early Goal-Directed Therapy (EGDT) protocol. This study also involved a comparative analysis of its findings on EGDT with those from a 2001 study by Rivers et al., providing insights into the evolution and implementation of the EGDT protocol over time.\",56\n676,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,EGDT,The National Institute of General Medical Sciences was consulted regarding the study design involving EGDT,53\n699,PROTOCOL-BASED STANDARD THERAPY,EGDT,Protocol-based standard therapy was compared to EGDT in the study,53\n235,UNITED STATES,PROCESS TRIAL,The ProCESS trial was conducted in 31 emergency departments across the United States,22\n115,APACHE II SCORE,PROCESS TRIAL,The ProCESS trial used the APACHE II score to analyze subgroups of patients based on illness severity,19\n691,RIVERS ET AL.,CONSERVATIVE-STRATEGY GROUP,\"Rivers et al. demonstrated early resuscitation efficacy, contrasting with the conservative-strategy group's later intervention\",17\n678,EDWARDS LIFESCIENCES,PROCESS TRIAL,Edwards Lifesciences provided ScvO2 monitoring equipment for the ProCESS trial,16\n685,PROCESS TRIAL,RIVERS ET AL.,\"The ProCESS trial was conducted to test the findings of Rivers et al. regarding Early Goal-Directed Therapy (EGDT). The results of the ProCESS trial are compared with those of the study conducted by Rivers et al., providing a comprehensive analysis of EGDT's effectiveness.\",16\n684,PROCESS TRIAL,EARLY GOAL-DIRECTED THERAPY (EGDT),The ProCESS trial tested the effectiveness of EGDT compared to other resuscitation strategies,13\n675,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,PROCESS TRIAL,The National Institute of General Medical Sciences funded the ProCESS trial,13\n683,CRISMA CENTER,PROCESS TRIAL,The CRISMA Center managed data for the ProCESS trial,12\n680,EDWARDS LIFESCIENCES,PROMISE STUDY,\"Edwards Lifesciences is mentioned in the context of the ProMISe study, possibly as a collaborator or equipment provider\",12\n686,PROCESS TRIAL,SERUM LACTATE LEVEL,The ProCESS trial used serum lactate levels to analyze subgroups of patients based on shock severity,12\n677,UNIVERSITY OF PITTSBURGH,PROCESS TRIAL,The University of Pittsburgh managed the data for the ProCESS trial,12\n681,EDWARDS LIFESCIENCES,CLINICAL TRIALS UNIT,Edwards Lifesciences provided equipment and support for the study managed by the Clinical Trials Unit,9\n688,RIVERS ET AL.,EARLY GOAL-DIRECTED THERAPY (EGDT),Rivers et al. reported the effectiveness of EGDT in reducing mortality in 2001,7\n689,RIVERS ET AL.,PROTOCOL-BASED EGDT,The protocol-based EGDT intervention was designed to mimic the protocol used by Rivers et al.,7\n682,EDWARDS LIFESCIENCES,IRVINE,\"Edwards Lifesciences is located in Irvine, California\",6\n697,PROTOCOL-BASED EGDT,PROCESS INVESTIGATORS,The ProCESS investigators designed the protocol-based EGDT intervention,4\n698,PROTOCOL-BASED STANDARD THERAPY,PROCESS INVESTIGATORS,The ProCESS investigators designed the protocol-based standard-therapy intervention,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}